Cyclooxygenase 2 (COX-2) is widely accepted to be implicated in CRC progression and metastasis, as well as an important therapeutic target for treatment or prevention of this type of cancer (Doherty and Murray, 2009; Wang and DuBois, 2010). The gene discussed is PTGS2; the disease is cancer.